You are here

JNJ

J&J bags first nod for multiple myeloma bispecific to complement its own CAR-T offering

Fierce Pharma

Thu, 08/25/22 - 07:43 pm

bispecific antibodies

Multiple Myeloma

AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease

Fierce Pharma

Thu, 08/25/22 - 11:04 am

graft vs host disease

Johnson & Johnson lost to Pfizer in bidding war for Global Blood Therapeutics: Bloomberg

Fierce Pharma

Wed, 08/24/22 - 10:34 am

Global Blood Therapeutics

ESC 2022 preview – who’s got the XI factor?

EP Vantage

Tue, 08/23/22 - 10:23 am

Bristol Myers Squibb

After billions in legal costs, Johnson & Johnson plans to halt talc sales worldwide

Fierce Pharma

Fri, 08/12/22 - 10:46 am

Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial

Fierce Biotech

Wed, 08/10/22 - 10:49 am

monoclonal antibodies

clinical trials

Johnson & Johnson And Hospital Giant HCA To Tackle Health Equity

Forbes

Tue, 08/9/22 - 10:35 am

AI innovation among clinical trial companies dropped in the past quarter

Clinical Trials Arena

Mon, 08/8/22 - 10:05 am

clinical trials

artificial intelligence

J&J nabs label expansion for Stelara in pediatric psoriatic arthritis

Endpoints

Tue, 08/2/22 - 12:03 am

psoriatic arthritis

Johnson & Johnson isn't finished with Emergent dispute, files arbitration demand

Fierce Pharma

Mon, 08/1/22 - 11:56 pm

Emergent BioSolutions

Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts

Fierce Pharma

Mon, 08/1/22 - 10:53 am

Go or no go? J&J’s bispecific FDA first

EP Vantage

Thu, 07/28/22 - 11:04 am

Amicus Therapeutics

J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion

Fierce Pharma

Wed, 07/27/22 - 10:28 am

J&J looks to expand Rybrevant lung cancer indication to larger EGFR-positive population

Endpoints

Tue, 07/26/22 - 11:03 am

non-small cell lung cancer

J&J Strengthens Its Stronghold in Medtech

Medical Devices and Diagnostics Industry

Mon, 07/25/22 - 10:40 am

Johnson & Johnson beats on Q2 earnings, cuts forecast

Yahoo Finance

Tue, 07/19/22 - 09:57 pm

Medtech research spending set to slow in 2022

EP Vantage

Tue, 07/5/22 - 10:57 am

Becton Dickinson

Boston Scientific

EssilorLuxottica

Siemens Healthineers

Janssen secures FDA breakthrough designation for myeloma therapy

Pharmaceutical Business Review

Thu, 06/30/22 - 10:54 am

breakthrough therapy

Multiple Myeloma

relapsed or refractory multiple myeloma

Big pharma’s key third-quarter data

EP Vantage

Tue, 06/28/22 - 10:37 am

Novo Nordisk vaccines

clinical trials

pneumococcal disease

rheumatoid arthritis

J&J Develops Contacts to Address Digital Eye Strain

Medical Devices and Diagnostics Industry

Mon, 06/20/22 - 08:19 pm

digital eyestrain

Pages